EUVIMEDEUVIMED entdecken
Open Access

The impact of arsenic exposure on DNA methylation in humans: building an epigenetic biomarker of exposure across three independent cohorts

James L Li iD, Niyati Jain, Lizeth I Tamayo, Lin Tong, Kathryn Demanelis, Farzana Jasmine, Muhammad G Kibriya, Lin S Chen, Arce Domingo-Relloso iD, Anne K Bozack, Ana Navas-Acien iD, Habibul Ahsan und 1 weitere

International Journal of Epidemiology · 17.04.2026 · 55 (3)

DOI: 10.1093/ije/dyag056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Epidemiology, online erschienen am 29.04.2026. Verfasst von James L Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, University of Chicago, Chicago, IL 60637, United States. Hauptthemen laut MEDLINE: DNA Methylation, Arsenic, Environmental Exposure, Water Pollutants, Chemical. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Susan G. Komen Breast Cancer Foundation, National Institute of General Medical Sciences of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inorganic arsenic (As) is a carcinogen and >200 million people worldwide are exposed to As through drinking water. Long-term As exposure increases the risk of chronic diseases including cancer and cardiovascular disease. While prior work has identified several genomic regions where DNA methylation (DNAm) is associated with As exposure, our knowledge remains limited.

Methods

We first evaluated the association of As exposure (measured in urine and drinking water) with DNAm (measured genome-wide in blood cells at >720 000 cytosine-phosphate-guanine (CpG) sites) among 1186 Bangladeshi adults from the Health Effects of Arsenic Longitudinal Study—a population with a wide range of As exposure levels. We then utilized elastic net regression to build a DNAm-based biomarker of As exposure.

Results

We identified 1177 CpGs associated with urinary As (false discovery rate < 0.05) and further demonstrated that these associations are likely causal by using genetic determinants of As metabolism as instrumental variables. Arsenic-associated CpGs showed strong enrichment for genomic context and CpG sets related to disease states previously linked to As exposure. We developed a 255-CpG DNAm-based biomarker of As exposure that was highly predictive of urinary As levels (r2 = 0.46) and arsenical skin-lesion status (area under the receiver-operating characteristic curve = 0.69)—a common sign of As toxicity. This biomarker was also highly associated with measured urinary As levels in an independent Bangladeshi cohort (P = 1.3 × 10−19) and further validated in the Strong Heart Study (P = 6.7 × 10−6), in which the DNAm-predicted As was also associated with overall mortality (P = 4.6 × 10−4).

Conclusion

We demonstrate the utility of a DNAm-based biomarker of As exposure that can predict the risk of toxicity and present guidelines for developing epigenetic biomarkers to track environmental chemical exposures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationArsenicEnvironmental ExposureWater Pollutants, ChemicalHumansBiomarkersFemaleBangladeshMaleAdultEpigenesis, GeneticCpG IslandsMiddle AgedLongitudinal StudiesDrinking Water

Stichwörter der Autor:innen

DNA methylationEWASMendelian randomizationarsenicbiomarkerenvironmental exposures

Substanzen

ArsenicBiomarkersDrinking WaterWater Pollutants, Chemical

Autor:innen und Institutionen

  • Department of Public Health Sciences, University of Chicago, Chicago, IL 60637, United States.
  • Interdisciplinary Scientist Training Program, University of Chicago, Chicago, IL 60637, United States.
  • Committee on Genetics, Genomics, Systems Biology, University of Chicago, Chicago, IL 60637, United States.
  • Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, United States.
  • Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY 10032, United States.
  • Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY 10032, United States.

ORCID-Profile: James L Li, Arce Domingo-Relloso, Ana Navas-Acien

Förderung

  • NIH HHS
  • Susan G. Komen Breast Cancer Foundation
  • National Institute of General Medical Sciences of the National Institutes of Health
  • NHLBI NIH HHS
  • National Institute of Health, Department of Health and Human Services
  • NIEHS NIH HHS
  • the Indian Health Service
  • National Institutes of Health

Zitieren

APA

Li, J. L., Jain, N., Tamayo, L. I., Tong, L., Demanelis, K., Jasmine, F., Kibriya, M. G., Chen, L. S., Domingo-Relloso, A., Bozack, A. K., Navas-Acien, A., Ahsan, H., & Pierce, B. L. (2026). The impact of arsenic exposure on DNA methylation in humans: building an epigenetic biomarker of exposure across three independent cohorts. International Journal of Epidemiology, 55(3). https://doi.org/10.1093/ije/dyag056

Vancouver

Li JL, Jain N, Tamayo LI, Tong L, Demanelis K, Jasmine F, et al. The impact of arsenic exposure on DNA methylation in humans: building an epigenetic biomarker of exposure across three independent cohorts. International Journal of Epidemiology. 2026;55(3). doi:10.1093/ije/dyag056

BibTeX
@article{Li2026,
  author = {Li, James L and Jain, Niyati and Tamayo, Lizeth I and Tong, Lin and Demanelis, Kathryn and Jasmine, Farzana and Kibriya, Muhammad G and Chen, Lin S and Domingo-Relloso, Arce and Bozack, Anne K and Navas-Acien, Ana and Ahsan, Habibul and Pierce, Brandon L},
  title = {The impact of arsenic exposure on DNA methylation in humans: building an epigenetic biomarker of exposure across three independent cohorts},
  journal = {International Journal of Epidemiology},
  year = {2026},
  volume = {55},
  number = {3},
  doi = {10.1093/ije/dyag056}
}
Kostenlos starten →